InMed Pharmaceuticals Inc. Annual Income Tax Expense (Benefit) in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
InMed Pharmaceuticals Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate for 2023.
  • InMed Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $6.8K.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.1K Jul 1, 2022 Jun 30, 2023 10-K 2023-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.